A renowned, focused and innovative player developing targeted therapies to treat cancer
Cancer causes more than one in six of all deaths, making it the second leading cause of death in the world,1 and numbers are on the rise. To address the growing need for therapeutic solutions, we have made oncology one of our priorities. We invest over half of our R&D budget in oncology, with a view to becoming a renowned, focused and innovative player in cancer treatments.
For a company of our size, we are aiming in oncology to become:
among health care
patients for our commitment
on rare cancers,
and action drivers
by creating open ecosystems, investing heavily in R&D and developing precision medicine
A three-pronged approach to our oncology strategy
To step up the pace of research and development in innovative treatments, we unrelentingly promote and pursue open innovation with pharmaceutical labs, biotech companies, prestigious academic institutions and start-ups.
In oncology, we have formed around 40 research partnerships and collaborations.
7 oncology treatments available for patients throughout the world
Learn more about our oncology development projects
Understanding digestive cancers: Insight
Improving patients’ quality of life
We have published a number of brochures developed in collaboration with expert patients, patient representatives, carers and health care professionals. Written for patients living with digestive cancers to support them, as well as their family, throughout their cancer journey, these brochures form part of SHAPE,2 an international program launched by Servier in collaboration with Digestive Cancers Europe.
Everything there is to know about acute lymphoblastic leukemia
This cancer, that involves the bone marrow, affects a particular type of white blood cells, lymphoblasts (lymphocytes at an early stage of development). It is the most common leukemia in children, although it affects all age groups.
Understanding acute myeloid leukemia
Acute myeloid leukemia (AML) is a rare disease which mainly affects the elderly. It is a blood and bone marrow cancer which develops rapidly without therapeutic treatment.
Got a question?
Want to report a side effect?
Check out our Pharmacovigilance page.
 World Health Organization
 “Support Harmonized Advances for better Patient Experiences”